RE: Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
- PMID: 35460254
- PMCID: PMC9552270
- DOI: 10.1093/jnci/djac082
RE: Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
Comment on
-
Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.J Natl Cancer Inst. 2022 Jun 13;114(6):878-884. doi: 10.1093/jnci/djac050. J Natl Cancer Inst. 2022. PMID: 35262727 Free PMC article.
-
Response to Lehrer and Rheinstein.J Natl Cancer Inst. 2022 Oct 6;114(10):1427-1428. doi: 10.1093/jnci/djac083. J Natl Cancer Inst. 2022. PMID: 35460256 Free PMC article. No abstract available.
References
-
- Zhang XS, Zhang YM, Li B, et al. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: a meta-analysis. Gynecol Oncol. 2018;150(3):509–514. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
